STOCKWATCH
·
Pharmaceuticals
Quarterly Result6 Nov 2025, 08:23 pm

Sai Life Sciences Ltd Reports 1,734.62% YoY Profit Growth in Q2 FY2026

AI Summary

Sai Life Sciences Ltd has announced its unaudited financial results for the quarter and half year ended on 30 September 2025. The company has reported a significant profit growth of 1,734.62% YoY, amounting to INR 1,734.62 million in Q2 FY2026. The revenue from operations stands at INR 10,097.07 million, a 51.18% YoY increase. The net profit for the half year ended on 30 September 2025 is INR 3,950.07 million, a 1,261.60% YoY growth.

Key Highlights

  • Profit for the quarter is INR 1,734.62 million, a 1,734.62% YoY increase.
  • Revenue from operations stands at INR 10,097.07 million, a 51.18% YoY increase.
  • Net profit for the half year ended on 30 September 2025 is INR 3,950.07 million, a 1,261.60% YoY growth.
  • Earnings per equity share (basic) is INR 9.00.
  • Earnings per equity share (diluted) is INR 8.78.
SAILIFE
Pharmaceuticals
Sai Life Sciences Ltd

Price Impact